Cargando…

A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values

BACKGROUND: Differential diagnosis of high-grade dysplastic nodules (HGDN) and well-differentiated hepatocellular carcinoma (WDHCC) represents a challenge to experienced hepatic clinicians, radiologists and hepatopathologists. METHODS: The expression profiles of aminoacylase-1 (ACY1), sequestosome-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Guang-Zhi, Dong, Hui, Yu, Wen-Long, Li, Yan, Lu, Xin-Yuan, Yu, Hua, Xian, Zhi-Hong, Dong, Wei, Liu, Yin-Kun, Cong, Wen-Ming, Wu, Meng-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621586/ https://www.ncbi.nlm.nih.gov/pubmed/23537217 http://dx.doi.org/10.1186/1471-2407-13-161

Ejemplares similares

Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules
por: Luo, Qin, et al.
Publicado: (2015)

The stromal morphological changes for differential diagnosis of uninodular high-grade dysplastic nodule and well-differentiated small hepatocellular carcinoma
por: Feng, Long-Hai, et al.
Publicado: (2017)

Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma
por: Gong, Li, et al.
Publicado: (2014)

Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI
por: Di Martino, Michele, et al.
Publicado: (2016)

Promoter Methylation of E-cadherin in Hepatocellular Carcinomas and Dysplastic Nodules
por: Kwon, Ghee Young, et al.
Publicado: (2005)

Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma
por: Joung, Je-Gun, et al.
Publicado: (2016)

Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers
por: Lu, Lina, et al.
Publicado: (2017)

Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature
por: Peng, Chengyuan, et al.
Publicado: (2016)

Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis
por: Gazelakis, Kathryn, et al.
Publicado: (2021)

Early hepatocellular carcinoma developed within dysplastic nodule as nodule-within-nodule appearance: Case report with literature review
por: Aassouani, Farid, et al.
Publicado: (2022)

Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver
por: Li, Ruo-kun, et al.
Publicado: (2015)

Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study
por: Sato, Tsunenobu, et al.
Publicado: (2015)

Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney
por: Xu, Jing, et al.
Publicado: (2013)

The so-called dysplastic nevus is not dysplastic at all
por: Madan, Raman, et al.
Publicado: (2013)

The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma
por: Jin, Guang-Zhi, et al.
Publicado: (2015)

The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules
por: Ling, Zhougui, et al.
Publicado: (2021)

Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
por: Beudeker, Boris J.B., et al.
Publicado: (2023)

Predictive Value of Positive Margins in Diagnostic Biopsies of Dysplastic Nevi
por: Dickman, Jeffrey S., et al.
Publicado: (2020)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma
por: Rizzo, Francesca, et al.
Publicado: (2016)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma
por: Yu, Hua, et al.
Publicado: (2020)

A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules
por: Liang, Meihua, et al.
Publicado: (2020)

Computed Tomography during Arteriography and Arterial Portography in Small Hepatocellular Carcinoma and Dysplastic Nodule: A Prospective Study
por: Mikami, Shinichi, et al.
Publicado: (2000)

A five‐gene panel refines differential diagnosis of thyroid nodules
por: Lu, Sang‐Yu, et al.
Publicado: (2021)

Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer
por: Han, Lei, et al.
Publicado: (2021)

A panel of four genes accurately differentiates benign from malignant thyroid nodules
por: Wang, Qing-Xuan, et al.
Publicado: (2016)

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression
por: Sung, Wei-Wen, et al.
Publicado: (2021)

COCH predicts survival and adjuvant TACE response in patients with HCC
por: Wang, Chen, et al.
Publicado: (2021)

Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma
por: Huang, Xiaofeng, et al.
Publicado: (2023)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

An Overview of Biomarkers and Molecular Signatures in HCC
por: Yim, Seon-Hee, et al.
Publicado: (2010)

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC
por: Wang, Dong, et al.
Publicado: (2020)

Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2019)

Erratum: Lina Lu et al.; Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers. Genes 2017, 8, 268
por: Lu, Lina, et al.
Publicado: (2019)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions
por: Brenes, David R., et al.
Publicado: (2022)

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
por: Feng, Long-Hai, et al.
Publicado: (2023)

Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’ Pulmonary Nodules
por: Auger, Claire, et al.
Publicado: (2023)

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy
por: Feng, Hanxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0etgl7gtpqk7t2ccq5oe9vodj